BOHEMIA, N.Y., June 25, 2018 /PRNewswire/ — The LGS Foundation is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX® (cannabidiol / CBD) for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients two years age or older. EPIDIOLEX® is the first prescription pharmaceutical formulation of highly purified CBD […]

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana. […]

According to the data compiled by Ameri Research, the global legal cannabis market is projected to be valued at USD 63.5 Billion by 2024. The market drivers are largely the new legalization laws, increasing medical usage, high taxation and rising investments. Legalization has become so prominent that now only four out of the fifty U.S. […]

<!– var articlecredit = []; var articlecaption = []; var articleimage = []; –> At 3 months old, Marissa Parsons began having frequent seizures, some lasting a half-hour. For… read more at: http://www.watertowndailytimes.com/national/pot-derived-anti-seizure-drug-tested-20180625

Axim Biotech announced that its way of extracting and purifying THC (delta-9-tetrahydrocannabinol) — an active compound in medical cannabis — has been approved to receive a patent. The notice of allowance for patient No. 15/146668 came in letter from the United States Patent and Trademark Office (USPTO), Axim said in a press release. Axim specializes in the research […]

Updated 11 hours ago At 3 months old, Marissa Parsons began having frequent seizures, some lasting a half-hour. For almost two decades, her desperate parents tried drug after drug to treat her rare type of childhood epilepsy, but the medications mostly produced side effects — pancreatitis, hives and extreme drowsiness — and she was frequently […]

Twelve new drugs targeting a broad spectrum of indications are predicted to achieve blockbuster status by 2022, according to the newly released 2018 edition of Drugs to Watch, the annual industry forecast and analysis from Clarivate Analytics. Emanating from the pipelines of global pharma giants like Novartis, Johnson Johnson and Pfizer, as well companies such […]

Marissa Parsons and her family visit the Grand Canyon in 2016. (Ronda Parsons) At 3 months old, Marissa Parsons began having frequent seizures, some lasting a half-hour. For almost two decades, her desperate parents tried drug after drug to treat her rare type of childhood epilepsy, but the medications mostly produced side effects — pancreatitis, […]

Marissa Parsons and her family visit the Grand Canyon in 2016. (Ronda Parsons) At 3 months old, Marissa Parsons began having frequent seizures, some lasting a half-hour. For almost two decades, her desperate parents tried drug after drug to treat her rare type of childhood epilepsy, but the medications mostly produced side effects — pancreatitis, […]

<!– Trending Stock News –> June 22, 2018 – By Henry Gaston Supplemental Annuity Collective Trust Of Nj decreased Jpmorgan Chase Co (JPM) stake by 11.11% reported in 2018Q1 SEC filing. Supplemental Annuity Collective Trust Of Nj sold 5,500 shares as Jpmorgan Chase Co (JPM)’s stock declined 6.83%. The Supplemental Annuity Collective Trust Of Nj […]

His product was called Preleve, an herbal blend that included curcumin, the active ingredient in turmeric and a natural anti-inflammatory. The key factor was making sure the herb was pure and water-soluble, so it could be efficiently absorbed by humans. “You can take curcumin all day long,” says Martin. “But unless you have a good […]

There is currently no effective treatment for atopic dermatitis and Botanix claims its BTX 1204 has strong potential. Medical dermatology company Botanix Pharmaceuticals (ASX: BOT) has raised A$8 million through an oversubscribed placement to professional, institutional and sophisticated investors across Australia and Asia. The raising comes at a critical juncture in the company’s development as it looks […]